Loading…

Can serum periostin predict bronchopulmonary dysplasia in premature infants?

Bronchopulmonary dysplasia (BPD) is the most common morbidity complicating preterm birth and affects long-term respiratory outcomes. The objectives of this study were to establish whether serum periostin at birth, day of life (DOL) 28, and corrected 36 weeks' gestational age could be potential...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric research 2022-10, Vol.92 (4), p.1108-1114
Main Authors: Go, Hayato, Ono, Junya, Ohto, Hitoshi, Nollet, Kenneth E, Sato, Kenichi, Kume, Yohei, Maeda, Hajime, Chishiki, Mina, Haneda, Kentaro, Ichikawa, Hirotaka, Kashiwabara, Nozomi, Kanai, Yuji, Ogasawara, Kei, Sato, Maki, Hashimoto, Koichi, Nunomura, Satoshi, Izuhara, Kenji, Hosoya, Mitsuaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bronchopulmonary dysplasia (BPD) is the most common morbidity complicating preterm birth and affects long-term respiratory outcomes. The objectives of this study were to establish whether serum periostin at birth, day of life (DOL) 28, and corrected 36 weeks' gestational age could be potential biomarkers for BPD. A total of 98 preterm Japanese infants born at 
ISSN:0031-3998
1530-0447
DOI:10.1038/s41390-021-01912-w